MANA RBM - Risk-Based Monitoring

MANA RBM - Risk-Based Monitoring Leaders in Clinical Research Innovation MANA RBM is your expert source for implementing Monitoring for Clinical Research.

Risk-Based Monitoring is the recommended approach for quality oversight for all clinical trials using Investigational Products (medicines, vaccines, and devices). The approach is based in the principles of Quality by Design and is recommended by the Food and Drug Administration (FDA), European Medicines Agency (EMA), and the International Council on Harmonization (ICH). MANA RBM supports design of

processes, technology and training for staff on the new methods required for Risk-Based Monitoring. Alternative options from MANA RBM include MANA and partners functioning as a Clinical Research Organization or providing a Knowledge Transfer to your organization.

The best way to address a future   is to prevent it from ever occurring. With some of the recent developments related to...
07/26/2021

The best way to address a future is to prevent it from ever occurring. With some of the recent developments related to the vaccines, it feels like a worthy investment to try avert another .

If funded, a government program costing several billion dollars could develop “prototype” vaccines to protect against 20 families of viruses.

The myth of the "monolith" unvaccinated only allows the myth to become reality. We shouldn't be surprised to see that my...
07/26/2021

The myth of the "monolith" unvaccinated only allows the myth to become reality. We shouldn't be surprised to see that myth be dispelled when we create a space for the curious to have their concerns addressed.

They’re not all anti-vaxxers, and treating them as such is making things worse.

07/23/2021

As we continue to move forward in the digital age, this becomes more true with each passing hour.

https://mck.co/3wQA0uo

If such a booster ends up being greenlit, one would hope it would at least benefit a high risk group. Otherwise, it begs...
07/23/2021

If such a booster ends up being greenlit, one would hope it would at least benefit a high risk group. Otherwise, it begs why an approval without data supporting one?

In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And …

07/22/2021

offer a variety of benefits to your recruitment process with convenience and education with being common components of this new process.

https://bit.ly/3BwhV8G

It's welcoming to see some theories at least in determining the cause of some   symptoms. If you're experiencing some of...
07/22/2021

It's welcoming to see some theories at least in determining the cause of some symptoms. If you're experiencing some of what is listed here, consider asking your physician about postural orthostatic tachycardia syndrome (POTS).

A significant number of post-covid patients suffer from syndromes that few doctors understand.

07/21/2021

As many re-open, it's easy imagining the Olympics serving as a nexus event for a whole new wave of cases all around the world.

https://bit.ly/36LsiqG

Even if you are vaccinated, you should exercise caution when going out. Vaccine efficacy varies across   and is never 10...
07/21/2021

Even if you are vaccinated, you should exercise caution when going out. Vaccine efficacy varies across and is never 100%.

The variant can dodge some of the immune system’s defenses, but is still vulnerable to vaccines.

After a number notable health crises in the past few decades, it feels warranted to prepare our defenses for the next ev...
07/20/2021

After a number notable health crises in the past few decades, it feels warranted to prepare our defenses for the next eventual outbreak instead of allowing ourselves to wander blindly into yet another unprepared.

COVID’s evolution signals the importance of rational vaccine design based on broadly neutralizing antibodies.

More and more we are seeing   begun to only largely affect those unvaccinated and skew younger. If you have yet to get v...
07/20/2021

More and more we are seeing begun to only largely affect those unvaccinated and skew younger. If you have yet to get vaccinated, there is no better time than the present.

Vaccines are absolutely helping blunt the impact of Covid-19 outbreaks. But uptake isn’t yet enough to preclude increases in deaths.

For those looking for some easier explanations regarding   vaccinations, the W.H.O. has put together this series to simp...
07/19/2021

For those looking for some easier explanations regarding vaccinations, the W.H.O. has put together this series to simplify information on the vaccines.

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.

Address

1401 Wewatta Street
Denver, CO
80202

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

(919) 556-9456

Alerts

Be the first to know and let us send you an email when MANA RBM - Risk-Based Monitoring posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MANA RBM - Risk-Based Monitoring:

Share